Catalent | CTLT - Current Liabilities


Catalent reported $1.1B in Current Liabilities for its fiscal quarter ending in June of 2025.



Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Bruker USD 1.28B 11.1M Dec/2025
Centene USD 36.7B 3.93B Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Cigna USD 56.34B 111M Dec/2025
Danaher USD 6.81B 483M Dec/2025
Dentsply International USD 1.34B 62M Dec/2025
Elevance Health USD 41.04B 157M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Glaxosmithkline GBP 28.68B 8.3B Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Humana USD 16.35B 166M Dec/2025
Illumina USD 1.59B 377M Dec/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Lonza CHF 3.58B 970M Dec/2024
McKesson USD 68.13B 100M Dec/2025
Merck EUR 9.04B 405M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Quest Diagnostics USD 2.28B 144M Dec/2025
Repligen USD 135.83M 4.69M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
UnitedHealth USD 115.53B 4.74B Sep/2025
Veradigm USD 253.09M 3.24M Sep/2022
Waters USD 1.24B 11.8M Dec/2025
West Pharmaceutical Services USD 654.9M 19.5M Dec/2025